Search bioRxivSearch

bioRxiv · 10.1101/2020.09.27.316141

Task-Free Recovery and Spatial Characterization of a P3-Like Global Network from Resting-State EEG

Abstract

Diagnosis of mental illness, testing of treatment effects, and design of prevention strategies all require brain-based biomarkers that can serve as effective targets of evaluation. The search for such markers often starts with a search for neural correlates from brain imaging studies with measures of functions and behavior of interest. Yet such an approach can produce erroneous results for correlations do not guarantee causation. Only when the markers map onto neurocomputationally-relevant parameters can such markers best serve the intended function. Here we take an alternative approach to begin with targeting the neuroanatomically and neurophysiologically well-defined neuromoduatory systems that are well positioned to serve the computational role of generating globally synchronized neural activity for the purpose of functional integration [1]. By applying second-order blind identification (SOBI) [2], a blind source separation algorithm (BSS), to five minutes of resting-state EEG data (n=13), we provide evidence to support our conclusion that neuroelectrical signals associated with synchronized global network activity can be extracted using the detailed temporal information in the on-going continuously recorded EEG, instead of event-related potentials (ERPs). We report reliable extraction of a SOBI component, which we refer to as the P3-like component, in every individual studied, replicating our earlier report on data from a single participant [3]. We show that individual differences in the neural networks underlying this P3-like component can be revealed in high dimensional space by a vector of hits-based measures [4] for each of the P3-like networks constituent structures. Given that resting-state EEG can be obtained with greater ease at natural non-hospital settings and at much lower cost in comparison with fMRI, and that mobile EEG systems have become increasingly available, the present work offers an enabling technology to support rapid and low-cost assessment of much larger and diverse populations of individuals, addressing several methodological limitations in our current investigation of brain function. Future opportunities and current limitations will be discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tang, A. C., Privitera, A. J.. 2020-09-28. Task-Free Recovery and Spatial Characterization of a P3-Like Global Network from Resting-State EEG. https://doi.org/10.1101/2020.09.27.316141

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience